1.Miller DJ, Ravikumar K, Shen H, Suh JK, Kerwin SM, Robertus JD.. (2002) Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition., 45 (1):[PMID:11754581][10.1021/jm010186s]
2.Hevener KE, Yun MK, Qi J, Kerr ID, Babaoglu K, Hurdle JG, Balakrishna K, White SW, Lee RE.. (2010) Structural studies of pterin-based inhibitors of dihydropteroate synthase., 53 (1):[PMID:19899766][10.1021/jm900861d]
3.PubChem BioAssay data set,
4.Yun MK, Hoagland D, Kumar G, Waddell MB, Rock CO, Lee RE, White SW.. (2014) The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase., 22 (7):[PMID:24613625][10.1016/j.bmc.2014.02.022]
5.Dennis ML, Chhabra S, Wang ZC, Debono A, Dolezal O, Newman J, Pitcher NP, Rahmani R, Cleary B, Barlow N, Hattarki M, Graham B, Peat TS, Baell JB, Swarbrick JD.. (2014) Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus., 57 (22):[PMID:25357262][10.1021/jm501417f]
6.Dennis ML, Pitcher NP, Lee MD, DeBono AJ, Wang ZC, Harjani JR, Rahmani R, Cleary B, Peat TS, Baell JB, Swarbrick JD.. (2016) Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli., 59 (11):[PMID:27094768][10.1021/acs.jmedchem.6b00002]
7. (2012) Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of Pain,